Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.

Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study. Am Heart J. 2017 Jun; 188:73-81.

View in: PubMed

subject areas

Acute Coronary Syndrome
Acute Coronary Syndrome
Aged
Aged
Cause of Death
Cause of Death
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Female
Female
Follow-Up Studies
Follow-Up Studies
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Prasugrel Hydrochloride
Preoperative Period
Preoperative Period
Purinergic P2Y Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Retrospective Studies
Retrospective Studies
Survival Rate
Survival Rate
Ticlopidine
Ticlopidine
Treatment Outcome
Treatment Outcome

authors with profiles

Usman Baber